两种不同方式经皮肝穿刺活组织检查的优缺点分析

doi:10.3969/j.issn.1672-5069.2010.03.003

Abstract

Abstract: Objective To investigate the sampling errors of two different ways of percutaneous liver biopsies. Methods The liver biopsy in 3059 patients were performed by Menghini needle and in 263 patients by automatic Tru-cut needle. Results The average length of samples by Menghini needle were 2.06±0.62cm,longer than by automatic Tru-cut（1.29±0.50cm,t=17.089,P=0.000);In 221 fragmented tissue samples obtained by Menghini,the liver cirrhosis were confirmed in 184 patients（83.26%）;In other 37 patients with fragmented samples without pathological diagnosis at first needle,the second needle by automatic Tru-cut showed liver cirrhosis in 35 patients（94.6%）. Conclusion The samples obtained by Menghini are longer than that by automatic Tru-cut. Nearly all the samples with fragmented tissues by suction needle in patients with hepatitis B are diagnosed as liver cirrhosis.

Key words: Percutaneous liver biopsy, Sampling errors, Hepatitis B, Liver cirrhosis

WANG Gongsui, WANG Manman, JIANG Xiangning, et al.. Comparative study of sampling errors of two different percutaneous liver biopsies[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2010, 13(3): 170-171.

References

[1] SALEH HA,ABU-RASHED AH. Liver biopsy remains the gold standard for evaluation of chronic hepatitis and fibrosis[J]. J Gastrointestin Liver Dis,2007,16:425-426.
[2] MANNING DS,AFDHAO NH. Diagnosis and quantitation of fibrosis[J]. Gastroenterology,2008,134:1670-1681.
[3] COLLOREDO G,GUIDO M,SONZOGNI A,et al. Impact of liver biopsy size on histological evaluation of chronic viral hepatitis:the smaller the sample,the milder the disease[J]. J Hepatol,2003,39:239-244.
[4] BRAVO AA,SHETH SG,CHOPRA S. Liver biopsy[J]. N Engl J Med,2001,344:495-500.
[5] 病毒性肝炎防治方案（试行）[J]. 中华肝脏病杂志,2000, 8:324-329.
[6] GUIDO M,RUGGE M. Liver biopsy sampling in chronic viral hepatitis[J]. Semin Liver Dis,2004,24:89-97.
[7] SCHEUER PJ. Liver biopsy size matters in chronic hepatitis: bigger is better[J]. Hepatology,2003,38:1356-1358.[8] SPOREA I,POPESCU A,SIRLI R. Why,who and how should perform liver biopsy in chronic liver diseases[J]. World J Gastroenterol,2008,14（21）:3396-3402.
[9] VARGAS T,MARTINEZ V,JIRON MI,et al. Tru-Cut and Menghini needles:different yield in the histological diagnosis of liver disease[J]. Liver,1985,5:178-181.
[10] COLOMBO M,DEL NINNO E,DE FRANCHIS R,et al. Ultrasound-assisted percutaneous liver biopsy: superiority of the Tru-Cut over the Menghini needle for diagnosis of cirrhosis[J]. Gastroenterology,1988,95:487-489.
[11] SPROREA I,POPESCU A,CORRNIANU M,et al. The quality of the fragment obtained by liver biopsy for staging chronic hepatitis[J]. J Gastrointestin Liver Dis,2007,16:263-266.
[12] VAN LEEUWEN DJ,WILSON L,CROWE DR. Liver biopsy in the mid-1990s:questions and answers[J]. Semin Liver Dis,1998,15:340-359.
[13] GILMORE IT,BURROUGHS A,MURRA-LYON IM,et al.Indications,methods and outcomes of percutaneous liver biopsy in England and Wales:an audit by the British society of Gastroenterology and the Royal collage of physicians of London[J]. Gut,1995,36:437-441.
[14] RILEY TR. How often does ultrasound marking change the liver biopsy site[J]. Am J Gastroenterol,1994,94:3320-3322.
[15] BEDOSSA P,DARGERE D,PARADIS V. Sampling variability of liver fibrosis in chronic hepatitis C[J]. Hepatology,2003,38:1449-1457.
[16] BRUNETTI E,SILINI E,PISTORIO A,et al. Coarse vs. fine needle aspiration biopsy for the assessment of diffuse liver disease from hepatitis C virus-related chronic hepatitis[J]. J Hepatol,2004,40:501-506.
[17] 王功遂,姜湘宁,明朗,等. 两种肝活组织检查方式的临床应用[J]. 中华肝脏病杂志,2009,17:135-136.
[18] PETZ D,KLAUCK S,ROHL FW. Feasibility of histological grading and staging of chronic viral hepatitis using specimens obtained by thin-needle biopsy[J]. Virchows Arch,2003,442（3）:238-244.
[191] MALIK AH,KUMAR KS,MALET PF,et al. Correlation of percutaneous liver biopsy fragmentation with the degree of fibrosis[J]. Aliment Pharmacol Ther,2004,19:545-549.
[20] PONIACHIK J,BEMSTEIN DE,REDDY KR,et al. The role of laparoscopy in the diagnosis of cirrhosis[J].Gastrointest Endosc,1996,43:568-571.

Comparative study of sampling errors of two different percutaneous liver biopsies

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Zhuang Ying, Lin Zhihui.. Clinical manifestations and diagnosis of portal vein thrombosis [J]. Journal of Practical Hepatology, 2019, 22(6): 765-767.
[2]	chronic hepatitis B Zhu Lingyun, Zhang Maohai Cui Shasha, et al.. Serum IL-12 and IL-18 levels as well as peripheral blood mononuclear cell FOXp3 in patients with [J]. Journal of Practical Hepatology, 2019, 22(6): 816-819.
[3]	Shi Yingying, Wang Yuanxi.. Impact of combination telbivudine and adefovir dipivoxil on renal functions in the treatment of patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(6): 820-823.
[4]	Min Feng, Huang Wenqi, Wu Weibing, et al.. Implications of serum adipocytokine levels in patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(6): 824-827.
[5]	patients with chronic hepatitis B Zhang Yingming, Shen Shuang, Tian Fei, et al.. Prediction of response to peginterferon alfa-2a by blood IFNL4 and IL-28B gene polymorphisms in [J]. Journal of Practical Hepatology, 2019, 22(6): 828-831.
[6]	chronic hepatitis B virus carriers Wu Haiyi, Chen Jianxin.. Diagnostic efficacy of four non-invasive diagnostic models in evaluating significant liver fibrosis in [J]. Journal of Practical Hepatology, 2019, 22(6): 832-835.
[7]	Ma Liying, Shen Lijuan.. Efficacy and safety of tenofovir in the treatment of pregnant women with high HBV DNA loads [J]. Journal of Practical Hepatology, 2019, 22(6): 836-839.
[8]	Yang Caiyong, Chen Na, Li Kui, et al.. Clinical significance of peripheral blood Treg and Th17 cells in patients with chronic hepatitis C and hepatitis C-induced liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(6): 868-871.
[9]	Wu Dan Ma Xiangying.. Insulin resistance,carotid atherosclerosis and left ventricular function in patients with NAFLD-induced liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(6): 876-879.
[10]	He Zhi’an, Yu Liping, Lai Jiangqiong, et al.. Evaluation of varices bleeding and portal vein thrombosis by ARFI in patients with cirrhosis and esophagogastric varices [J]. Journal of Practical Hepatology, 2019, 22(6): 888-891.
[11]	Li Chuanjie, Xu Jing, Wang Liangliang, et al.. Changes of serum HBsAg levels in patients with chronic hepatitis B receiving entecavir treatment [J]. Journal of Practical Hepatology, 2019, 22(6): 928-929.
[12]	Du Keye, Yang Dongliang, Liu Jia. Regulatory T cells in hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(5): 613-616.
[13]	Liao Guichan, Peng Jie, Zhang Xiaoyong. Roles of hepatocytes in intrinsic innate immunity in control of hepatits B virus infection [J]. Journal of Practical Hepatology, 2019, 22(5): 617-619.
[14]	Zhao Xieshan, Wu Chunrong, Wang Chunfeng, et al. Preliminary study on the efficacy of combination of tenofovir and Anluo Huaxian pill in the treatment of patients with HBeAg-negative chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(5): 644-647.
[15]	Tu Jiexia, Wang An’na, Liao Ruoxi. Comparative study of interferon alpha -2b and peginterferon alpha -2a in the treatment of patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(5): 648-651.